Antidepressant News and Research

RSS
Antidepressants are medicines that treat depression. Your doctor can prescribe them for you. They can improve your mood, sleep, appetite and concentration. It may take several weeks for them to help. There are several types of antidepressants. You and your doctor may have to try several before finding what works best for you.
Prolonged exposure to antidepressants can induce tardive dysphoria

Prolonged exposure to antidepressants can induce tardive dysphoria

Patients with epilepsy-linked memory loss worry more than their physicians

Patients with epilepsy-linked memory loss worry more than their physicians

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Preliminary top-line results from cariprazine 8-week Phase II trial against major depressive disorder

Preliminary top-line results from cariprazine 8-week Phase II trial against major depressive disorder

Role of serotonin in autism spectrum disorders

Role of serotonin in autism spectrum disorders

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Labs enters definitive merger agreement to acquire Clinical Data

Mouse model could help develop new classes of antidepressant drugs

Mouse model could help develop new classes of antidepressant drugs

Researchers use computers to capture chemical signal structure that triggers metastatic cancer

Researchers use computers to capture chemical signal structure that triggers metastatic cancer

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

Clinical Data reports $2.0 million revenue for third quarter 2011

Clinical Data reports $2.0 million revenue for third quarter 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

Study establishes direct link between morphine abstinence and depressive-like symptoms

Study establishes direct link between morphine abstinence and depressive-like symptoms

Patients with chronic depression can benefit from pioneering neurosurgical treatment

Patients with chronic depression can benefit from pioneering neurosurgical treatment

FDA approves Clinical Data's Viibryd for major depressive disorder

FDA approves Clinical Data's Viibryd for major depressive disorder

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.